EFG International AG Acquires New Position in HealthEquity, Inc. $HQY

Key Points

• EFG International acquired 41,028 HealthEquity shares worth approximately $3.7 million during the second quarter. Institutional investors collectively own 99.55% of the company.
• Analysts remain broadly bullish, with 11 Buy ratings and a consensus “Moderate Buy” rating. The average price target is $110.93, above HealthEquity’s reported opening price of $104.42.
• HealthEquity exceeded quarterly expectations, reporting $1.24 in EPS versus the $1.11 consensus and revenue of $354.64 million, up 7.2% year over year.

EFG International AG acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 41,028 shares of the company's stock, valued at approximately $3,706,000.

A number of other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. acquired a new position in shares of HealthEquity in the 2nd quarter valued at $1,018,621,000. Wasatch Advisors LP grew its stake in shares of HealthEquity by 10.5% during the second quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company's stock worth $719,014,000 after purchasing an additional 757,801 shares during the period. Geode Capital Management LLC increased its holdings in HealthEquity by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company's stock valued at $201,685,000 after purchasing an additional 5,671 shares during the last quarter. Westfield Capital Management Co. LP increased its holdings in HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company's stock valued at $178,864,000 after purchasing an additional 235,794 shares during the last quarter. Finally, William Blair Investment Management LLC acquired a new position in HealthEquity in the fourth quarter valued at about $169,956,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Weiss Ratings upgraded HealthEquity from a "hold (c)" rating to a "hold (c+)" rating in a report on Friday, June 5th. Royal Bank Of Canada upped their price target on HealthEquity from $100.00 to $108.00 and gave the company an "outperform" rating in a research note on Wednesday, June 3rd. Citizens Jmp increased their price target on shares of HealthEquity from $110.00 to $111.00 and gave the company a "market outperform" rating in a research report on Monday, June 1st. Barrington Research reissued an "outperform" rating and set a $110.00 price objective on shares of HealthEquity in a research note on Friday, May 22nd. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a report on Saturday, August 22nd. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, HealthEquity presently has a consensus rating of "Moderate Buy" and an average target price of $110.93.

Insider Buying and Selling at HealthEquity

In related news, EVP Michael Henry Fiore sold 3,142 shares of the business's stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the transaction, the executive vice president directly owned 59,113 shares in the company, valued at approximately $5,615,735. The trade was a 5.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 7,966 shares of company stock worth $756,770. Insiders own 1.60% of the company's stock.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $104.42 on Thursday. The stock's fifty day simple moving average is $97.77 and its 200 day simple moving average is $87.71. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.73 billion, a PE ratio of 39.11, a PEG ratio of 1.77 and a beta of 0.21. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $107.62.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million during the quarter, compared to analysts' expectations of $352.02 million. The firm's revenue was up 7.2% on a year-over-year basis. On average, research analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.